IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Ranbaxy Buys Biopharma Stake

1:20 PM MDT | October 22, 2007 | Chemical Week Editorial Staff

India’s largest pharmaceutical company Ranbaxy Laboratories (Gurgaon), says it has signed a definitive agreement to increase its stake in Zenotech Laboratories (Hyderabad, India) from 7%, to 45%. Zenotech develops and manufactures generic biopharmaceuticals and is a specialty generics injectable company. It also develops new biological entities in the areas of oncology and neurology. “The increasing importance of biologics in the global pharmaceutical industry and the opening up of generic biologics in the regulated markets makes it opportune for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa